日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Cost-Effectiveness Analysis of Aztreonam-Avibactam (ATM-AVI) Versus Colistin + Meropenem (COL + MER) for the Treatment of Infections Caused by Metallo-β-Lactamase (MBL)-Producing Enterobacterales in Italy

意大利产金属β-内酰胺酶（MBL）肠杆菌感染治疗中，氨曲南-阿维巴坦（ATM-AVI）与粘菌素+美罗培南（COL+MER）的成本效益分析

期刊:Pharmacoeconomics
影响因子:4.6
doi:10.1007/s40273-025-01528-6
Falcone, Marco; Bao, Xiyu; Woodcock, Fionn; Di Virgilio, Roberto; Vidal Pereira, Maria Alejandra; Kantecki, Michal; Gheorghe, Maria
炎症/感染
ATM
COL
发表日期：2025
文献求助 收藏

Ceftaroline fosamil treatment patterns and outcomes in adults with community-acquired pneumonia: a real-world multinational, retrospective study

头孢洛林磷酸酯治疗成人社区获得性肺炎的治疗模式和疗效：一项真实世界多国回顾性研究

期刊:JACAntimicrobial Resistance
影响因子:3.7
doi:10.1093/jacamr/dlae078
Soriano, Alex; Bassetti, Matteo; Gogos, Charalambos; Ferry, Tristan; de Pablo, Raul; Ansari, Wajeeha; Kantecki, Michal; Schweikert, Bernd; Luna, Gustavo; Blasi, Francesco
肺炎
发表日期：2024
文献求助 收藏

Real-World Use and Treatment Outcomes of Ceftaroline Fosamil in Patients with Complicated Skin and Soft Tissue Infection: A Multinational Retrospective Study

头孢洛林磷酸酯在复杂性皮肤和软组织感染患者中的真实世界应用及治疗结果：一项多国回顾性研究

期刊:Infection and Drug Resistance
影响因子:2.9
doi:10.2147/IDR.S455515
Ferry, Tristan; Gogos, Charalambos; Soriano, Alex; Blasi, Francesco; Ansari, Wajeeha; Kantecki, Michal; Schweikert, Bernd; Luna, Gustavo; Bassetti, Matteo
炎症/感染
发表日期：2024
文献求助 收藏

Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Enterobacterales Analyzed by ICU and Non-ICU Wards, Infection Sources, and Geographic Regions: ATLAS Program 2016-2020

通过ICU和非ICU病房、感染源和地理区域分析阿兹特雷南-阿维巴坦和对照药物对肠杆菌科细菌的抗菌活性：ATLAS项目2016-2020

期刊:Antibiotics-Basel
影响因子:4.6
doi:10.3390/antibiotics12111591
Piérard, Denis; Hermsen, Elizabeth D; Kantecki, Michal; Arhin, Francis F
炎症/感染
微生物学
发表日期：2023
文献求助 收藏

Impact of Underlying Comorbidities on Outcomes of Patients Treated with Ceftaroline Fosamil for Complicated Skin and Soft Tissue Infections: Pooled Results from Three Phase III Randomized Clinical Trials

基础合并症对使用头孢洛林磷酸酯治疗复杂性皮肤和软组织感染患者预后的影响：三项 III 期随机临床试验的汇总结果

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-021-00557-w
Wilcox, Mark; Yan, Jean Li; Gonzalez, Pedro L; Dryden, Matthew; Stone, Gregory G; Kantecki, Michal
炎症/感染
发表日期：2022
文献求助 收藏

Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System

头孢洛林磷酸酯用于住院成人复杂性皮肤及软组织感染的经验性治疗：从西班牙国家卫生系统的角度进行的经济分析

期刊:
影响因子:
doi:10.2147/CEOR.S329494
Torres, Antoni; Soriano, Alex; Rivolo, Simone; Remak, Edit; Peral, Carmen; Kantecki, Michal; Ansari, Wajeeha; Charbonneau, Claudie; Hammond, Jennifer; Grau, Santiago; Wilcox, Mark
炎症/感染
发表日期：2022
文献求助 收藏

Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia

头孢洛林磷酸酯用于治疗儿童复杂性皮肤和软组织感染以及社区获得性肺炎

期刊:Pediatric Drugs
影响因子:3.3
doi:10.1007/s40272-021-00468-w
Esposito, Susanna; Carrothers, Timothy J; Riccobene, Todd; Stone, Gregory G; Kantecki, Michal
肺炎
炎症/感染
发表日期：2021
文献求助 收藏

Correction to: Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia

更正：头孢洛林磷酸酯用于治疗儿童复杂性皮肤和软组织感染以及社区获得性肺炎

期刊:Pediatric Drugs
影响因子:3.3
doi:10.1007/s40272-021-00474-y
Esposito, Susanna; Carrothers, Timothy J; Riccobene, Todd; Stone, Gregory G; Kantecki, Michal
肺炎
炎症/感染
发表日期：2021
文献求助 收藏

Baseline Characteristics and Outcomes Among Patients with Complicated Skin and Soft Tissue Infections Admitted to the Intensive Care Unit: Analysis of the Phase 3 COVERS Randomized Trial of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam

入住重症监护室的复杂性皮肤和软组织感染患者的基线特征和结局：头孢洛林磷酸酯与万古霉素联合氨曲南治疗的3期COVERS随机试验分析

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-020-00297-3
Sánchez-García, Miguel; Hammond, Jennifer; Yan, Jean Li; Kantecki, Michal; Ansari, Wajeeha; Dryden, Matthew
炎症/感染
发表日期：2020
文献求助 收藏

Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis

阿尼芬净治疗念珠菌血症和其他侵袭性念珠菌病的成本效益分析

期刊:BMC Infectious Diseases
影响因子:3
doi:10.1186/s12879-015-1143-1
Auzinger, Georg; Playford, E Geoffrey; Graham, Christopher N; Knox, Hediyyih N; Weinstein, David; Kantecki, Michal; Schlamm, Haran; Charbonneau, Claudie
发表日期：2015
文献求助 收藏